The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
Chia Siang Chia KowLearn-Han LeeDinesh Sangarran RamachandramSyed Shahzad HasanLong Chiau MingHui Poh GohPublished in: Immunity, inflammation and disease (2021)
The ability of colchicine to reduce the length of stay in hospitalized patients with COVID-19 is consistent with its potential to prevent clinical deterioration via inhibition of NLRP3 inflammasome. Nevertheless, such beneficial effects of colchicine did not translate into mortality benefits in patients with COVID-19.